ABSTRACT
Estudio Transversal y Longitudinal Combinado sobre la Predicción del Síndrome Metabólico y la enfermedad Cardiovascular Mediante el uso de la Haemoglobina en los Ancianos

INTRODUCTION
Hypertension, hyperlipidaemia, hyperglycaemia and central obesity are conditions that may co-exist more often than by chance alone; thus, the term metabolic syndrome (MetS) is used to describe this constellation of metabolic disturbance (1) .
Although different diagnostic criteria have been proposed, the essential components of MetS remain unchanged (1-3). The diagnoses of MetS have important implications from the preventive medicine perspective as it is associated with diabetes mellitus and cardiovascular diseases [CVD] (4, 5).
Early recognition and intervention of MetS are likely to reduce the patients' mortality and morbidity. The acknowledgements of the risk factors for MetS are also important, and they include: older age, postmenopausal status, current smoking, genetic predisposition and physical inactivity etc (6) . The current pathogenesis for MetS suggests the involvement of proinflammatory, prothrombotic and insulin resistance and hyperinsulin state (1) .
Numerous studies have demonstrated the association between MetS and inflammatory markers such as C-reactive protein, ferritin, haptoglobin, platelet and white blood cell and prothrombotic markers such as fibrinogen as well as haemoglobin (Hb) and erythropoietin level (7) (8) (9) (10) . Nevertheless, the majority of these studies were cross-sectional, therefore, a causal relationship cannot be firmly established.
To evaluate the association between Hb and MetS, we first performed a cross-sectional study comparing the Hb levels of patients with and without metabolic syndrome. In addition, a cut-off point of Hb with higher chances of having MetS was determined. Then, we conducted a longitudinal study in an attempt to validate if an elevated Hb is a risk factor for developing a metabolic syndrome. Since an elevated Hb level has been shown to be associated with CVD (11), we further investigated this association in our longitudinal study.
SUBJECTS AND METHODS
Study sample
Subjects aged 60 years and older who underwent routine health checkups at the MJ Health Screening Centre in Taiwan were enrolled. MJ Health Screening Centres are a privately-owned chain of clinics located throughout Taiwan that provide regular health examinations to their members. All the study's participants were anonymous and informed consent was obtained from them. Data were provided by MJ Health Screening Centre for research purposes only and the institutional review board of MJ Health Screening Centre approved the study's protocol.
We randomly selected 21 637 records from MJ Health Screening Centre's database between 1999 and 2007. Subjects with a past history of hypertension, diabetes and cardiovascular event and subjects taking medications known to affect the MetS components were all excluded (n = 8423). In addition, we excluded the subjects who visited only once (n = 2418) and had missing data of the MetS components (n = 217). Finally, a total of 10 579 subjects were eligible for analyses (Fig. 1) .
In the first part of the study, subjects were enrolled in the cross-sectional study to find out not only the association between Hb and MetS but also the best cut-off point of Hb in predicting the concurrence of MetS. In the second part of our study, we excluded 2861 subjects with MetS at the baseline from the same study group and performed the longitudinal study with 7718 subjects followed from the first to the ninth year (median 5.8 years). This part of the study was to validate whether the cut-off point for Hb at the baseline can successfully predict the development of MetS.
Anthropometric measurements and general data
Members of the senior nursing staff used a questionnaire to obtain the subjects' medical history, including any current medications. Complete physical examinations were performed. Waist circumference (WC) was measured horizontally at the level of the natural waist, which was identified as the level at the hollow molding of the trunk when the trunk was laterally concave. Body mass index (BMI) was calculated as the subject's bodyweight (kg) divided by the square of the subject's height (m). Both systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured by the nursing staff using standard mercury sphygmomanometers fitted on the right arm of each subject when seated. After the subjects fasted for 10 hours, blood samples were taken from the antecubital vein for biochemical analyses. Plasma was separated from the blood within one hour and stored at -30°C and analysed for fasting plasma glucose (FPG) and lipid profiles. The FPG was detected using a glucose oxidase method (YSI 203 glucose analyzer, Scientific Division, Yellow Springs Instruments, Yellow Springs, OH). The total cholesterol and triglycerides (TG) were measured using the dry, multilayer analytical slide method in the Fuji Dri-Chem 3000 analyser (Fuji Photo Film, Minato-Ku, Tokyo, Japan). Serum high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) concentration were analysed using an enzymatic cholesterol assay following dextran sulphate precipitation. Haemoglobin was measured with an Abbott Cell Dyn 3000 haematology analyser (Abbott Laboratories, Abbott Park, IL, USA).
Definition of MetS
We used the latest harmonized criteria of MetS in 2009 (3) with some modifications. Waist circumference ≥ 90 and 80 cm in Taiwanese men and women, respectively was used (12) . Other four criteria were the same: SBP ≥ 130 mmHg or DBP ≥ 85 mmHg, TG ≥ 150 mg/dL, FPG ≥ 100 mg/dL, HDL ≤ 40 and 50 mg/dL in men and women, respectively or taking relative medications. The subjects had to have at least three criteria to be diagnosed as MetS.
Statistical analyses
All the statistical analyses were done using SPSS 18.0 software (SPSS Inc., Chicago, IL). The data were presented as mean ± standard deviation. All the data were tested for normal distribution with Kolmogorov-Smirnov test and for homogeneity of variances with Levene's test. The t-test was used to determine the differences between the two groups. The correlations between MetS associated components and Hb were determined using the Pearson correlation. Multivariate linear regression analysis was performed to further confirm if Hb was independently related to MetS. The optimal cut-off point was calculated using the receiver operating characteristic (ROC) curves (MedCalc Software, Broekstraat, Mariakerke, Belgium). Kaplan-Meier plot and log rank test were done to deChao et al termine the differences among the different Hb levels at the baseline. Finally, cox regression was performed to determine the hazard ratio (HR) of the two different groups during the follow-up period. A p-value (two-sided) < 0.05 was considered to be significant.
RESULTS
The demographic data of this study's participants could be seen in Table 1 .
The Hb levels were significantly different in both genders with and without MetS. Except the HDL-C in the females, all the components of MetS and LDL-C were associated with Hb in the univariant analyses. Moreover, SBP failed to show any significance in the multivariant analyses only in the females. The cut-off point for Hb is shown in Figure 2 with area under curve (AUC) of 0.585 in the males and 0.575 in the females. 13.28 ± 0.98 13.53 ± 1.06 < 0.001
MetS (-), without metabolic syndrome; MetS (+), with metabolic syndrome; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Log TG, log transformation of triglyceride. Data are shown as mean ± SD Although the AUC was not good, it should be pointed out that this study's participants were healthier than the usual study population. Therefore, we lost the extreme end of the data to provide a higher AUC in the prediction of MetS. In the second part of this study, Hb was shown to be a good predictor of MetS in both genders with HR of 1.186 (1.026-1.370) in the men and 1.191 (1.045-1.358) in the women. The same results were seen in the Kaplan-Meier plot. Moreover, Hb was also a good predictor of future CVD in women with HR of 1.293 (1.010-1.656) and log rank test with p-value of 0.016. 
DISCUSSION
This study showed that Hb was significantly higher in the group with MetS than in the one without MetS. Moreover, a higher Hb level was associated with nearly all the components of MetS with the exception of HDL and SBP in the female sample. We further followed up the non-MetS group. The results demonstrated that Hb level above 14.6 and 13.7 pm/dL for the males and females, respectively, had a greater chance of having MetS. Elevated Hb level also has been shown to increase the risk for non-fatal CVD in the female but not in the male population. Many observational studies have revealed the correlation between elevated Hb with MetS (10, (13) (14) (15) . However, currently, there is no evidence suggesting that elevated Hb would lead to the development of MetS. Therefore, exactly how an elevated Hb level contributes to the development of MetS remains to be elucidated. Nevertheless, many observations made from previous studies might shed some light on the possible explanations. Studies have shown that increased oxidation and reduced oxygenation in the adipocyte of patients with central obesity, provide a possible underlying mechanism for insulin resistance (16, 17) . Insulin resistance or a hyperin-sulin state is known to be the main pathogenic process behind MetS (18) . Meanwhile, the overexpression of erythropoietin (EPO) gene transcription stimulating factor HIF-1 was also found in the adipose tissue of obese subjects (17, 19) . Erythropoietin serves as a strong stimulator for red blood cell production, subsequently resulting in elevated Hb level (20) . Therefore, this concurrent pathogenesis of erythropoesis and insulin resistance from adipocytes of patients with central obesity, may explain the correlation between elevated Hb and MetS (9, 10, 21).
Furthermore, insulin has a synergistic effect with erythropoetin on erythropoesis (21) . Although the above mentioned mechanism could well explain the correlation between Hb and MetS, how Hb contributes to the development of MetS still requires further investigations.
Another finding of the present study was the association of elevated Hb level as a risk factor for CVD in the female sample. This finding supports a recent prospective cohort study of 114 159 subjects which has shown the association between Hb and the risk of acute myocardial infarction (22) . The pathophysiological explanation for this observation may be that high Hb concentrations can increase blood viscosity; subsequently, it can increase coronary vascular resistance, decrease coronary blood flow and predispose the patients to thrombosis (11) . In addition, elevated red blood cell count has been shown to be an independent predictor of acute cardiovascular event such as stroke or myocardial infarction (23) . Further investigations, however, are required to clarify why, in our study, only the females with elevated HB were susceptible to CVD and not the males.
Haemoglobin was significantly correlated with either SBP or DBP in many studies (24) (25) (26) (27) (28) . This may be due to the effect of insulin on erythropoiesis, which activates tyrosine kinase in the insulin receptor that is essential for the growth-promoting action of insulin (29) . The results here are similar to the previously mentioned findings except for their failure to demonstrate the correlation between SBP and Hb in females. This may be due to the age difference in the present study. Arterial stiffness is known to occur with increasing age and may influence the relationship between Hb and SBP in elderly men. Meanwhile, HDL becomes insignificant after multivariate regression analyses with elderly women were inconsistent with those reported in other studies (30) . Despite the factor of age, all other studies enrolled study participants on medication. The strict exclusion criteria of the present study reflect the true relationship between MetS components that are different from the other studies in the available literature. Again, there is still a need to further investigate the gender differences recorded in this study.
This study, to our knowledge, is the first longitudinal study to establish that elevated Hb is a risk factor for developing MetS. However, there are many limitations in this study. One limitation was the population selection. This study was based on the Taiwanese population; thus, the findings in this study may not apply to other ethnic groups. Moreover, this study enrolled subjects from a health-screening centre which may have selection bias for the higher social economic status. Another limitation is not addressing smoking as a confounding factor. Smoking is a common cause of elevated haemoglobin level and is also a risk factor for MetS. This information nevertheless was not available for all our patients and therefore was not included in our study as an adjusting variable. However, the large number of this study's participants might reduce this bias.
CONCLUSION
This study suggests that elevated Hb increases the risk for developing MetS and it also increases the risk of developing CVD in females. The cut-off value for Hb was 14.6 and 13.7 for older males and females, respectively; therefore, haemoglobin can potentially be used as a marker to stratify the risks of developing MetS for both genders and CVD in the female population. Further studies are required to elucidate how elevated Hb contributes directly to the development of MetS and CVD.
